Ketogenic diet in epileptic children: Impact on lipoproteins and oxidative stress

Nutritional Neuroscience

Volumn 18, Issue 8, 2015, Pages 337-344

  Lima, Patricia Azevedo ^a   Sampaio, Leticia Pereira de Brito ^a   Damasceno, Nágila Raquel Teixeira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dyslipidemias; Epilepsy; Ketogenic diet; Lipid metabolism; Low density lipoprotein; Oxidative stress

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDIUM CHAIN TRIACYLGLYCEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACIDOSIS; CARDIOMETABOLIC RISK; DRUG RESISTANT EPILEPSY; DYSLIPIDEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERURICEMIA; HYPOCALCEMIA; KETOGENIC DIET; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER FAILURE; OXIDATIVE STRESS; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; REVIEW; ADOLESCENT; ADVERSE EFFECTS; BLOOD; CHILD; DIET THERAPY; EPILEPSY; FACTUAL DATABASE;

ADOLESCENT; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DATABASES, FACTUAL; EPILEPSY; HUMANS; HYPERCHOLESTEROLEMIA; KETOGENIC DIET; OXIDATIVE STRESS; TRIGLYCERIDES;

EID: 84951288106     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830515Y.0000000036     Document Type: Review

References (55)

1. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, v anEmde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;51:676–85.
2. Banerjee PN, Filippi D, Hauser WA. The descriptive epidemiology of epilepsy-a review. Epilepsy Res 2009;85:31–45.
3. Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009;50:304–17.
4. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo ClinProc 1921;2:307–8.
5. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008;7:500–6.
6. de Kinderen RJ, Lambrechts DA, Postulart D, Kessels AG, Hendriksen JG, Aldenkamp AP, et al. Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurol 2011;11:10.
7. Wang H, Lin K. Ketogenic diet: An early option for epilepsy treatment, instead of a last choice only. Biomed J 2013;36: 16.
8. Lee PR, Kossoff EH. Dietary treatments for epilepsy: management guidelines for the general practitioner. Epilepsy Behav 2011;21:115–21.
9. Liu Y-MC, Williams S, Basualdo-Hammond C, Stephens D, Curtis R. A prospective study: growth and nutritional status of children treated with the ketogenic diet. J Am Diet Assoc 2003;103:707–12.
10. Neal E, Cross J. Efficacy of dietary treatments for epilepsy. J Hum Nutr Diet 2010;23:113–9.
11. Kim DW, Kang HC, Park JC, Kim HD. Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics 2004;114:1627–30.
12. Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics 2007;119:535–43.
13. Kwiterovich PO, Vining EP, Pyzik P, Skolasky R, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003;290: 912–20.
14. Tumas R, Lopes CA, Marques-Dias MJ, Vieira MA. Ketogenic diet in epileptic children: clinical and laboratory assessment. Nutrición hospitalaria 2010;25:317.
15. Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol 2006;48:978–81.
16. Nizamuddin J, Turner Z, Rubenstein JE, Pyzik PL, Kossoff EH. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol 2008;23:758–61.
17. Patel A, Pyzik PL, Turner Z, Rubenstein JE, Kossoff EH. Longtermoutcomes of children treated with the ketogenic diet in the past. Epilepsia 2010;51:1277–82.
18. Liu Y-MC, Lowe H, Zak MM, Kobayashi J, Chan VW, Donner EJ. Can children with hyperlipidemia receive ketogenic diet for medication-resistant epilepsy? J Child Neurol 2013;28:479–83.
19. Huttenlocher P, Wilbourn A, Signore J. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1971;21:1097–103.
20. Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004;45:1116–23.
21. Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, et al. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 2012;53: 120–8.
22. Kim DW, Lee SY, Shon YM, Kim JH. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Epilepsia 2013;54:e146–149.
23. Pickrell WO, Lacey AS, Thomas RH, Smith PE, Rees MI. Weight change associated with antiepileptic drugs. J Neurol Neurosurg Psychiatry 2014;84:796–9.
24. Chukwu J, Delanty N, Webb D, Cavalleri GL. Weight change, genetics and antiepileptic drugs. Expert Rev Clin Pharmacol 2014;7:43–51.
25. Szaflarski JP, Bebin EM. Cannabis, cannabidiol, and epilepsyfrom receptors to clinical response. Epilepsy Behav 2014;41: 277–82.
26. Gloss D, Vickery B. Cannabinoids for epilepsy. Cochrane Database Syst Rev 2014;6:CD009270.
27. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 2009;50(1):376–81.
28. Steinberg D, Witztum JL. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol 2010;30:2311–6.
29. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011;12:204–12.
30. Brotons C, Ribera A, Perich RM, Abrodos D, Magaña P, Pablo S, et al. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis 1998;139:1–9.
31. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983;52:223–61.
32. Charach G, Rabinovich A, Argov O, Weintraub M, Charach L, Ayzenberg O, et al. Anti-oxidized low-density lipoprotein antibodies in chronic heart failure. World J Cardiol 2012;4: 302–8.
33. Ruskin DN, Masino SA. The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy. Front Neurosci 2012;6:33.
34. Mello AP, da Silva IT, Abdalla DS, Damasceno NR. Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis 2011;215:257–65.
35. Milder J, Patel M. Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res 2012;100: 295–303.
36. Gardner P, Fridovich I. Inactivation-reactivation of aconitase in Escherichia coli. A sensitive measure of superoxide radical. J Biol Chem 1992;267:8757–63.
37. Liang L, Ho Y, Patel M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 2000; 101:563–70.
38. Buelna-Chontal M, Zazueta C. Redox activation of Nrf2 & NFkB: a double end sword? Cell Signal 2013;25:2548–57.
39. Pan H, Wang H, Xiaoliang W, Zhu L, Mao L. The absence of Nrf2 enhances NF-KB-Dependent Inflammation following scratch injury in mouse primary cultured astrocytes. Mediators Inflamm 2012;2012:217-580.
40. Kensler TW, Wakabayashi N, Biswal S. Cell survival respo nsesto environmental stresses via the Keap1-Nrf2ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89–116.
41. Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW. When Nrf2 talks, who’s listening? Antioxid Redox Signal 2010; 13:1649–63.
42. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChlP-Seq profiling and network analysis. Nucleic Acids Res 2010;38:5718–34.
43. McPherson PAC, McEneny J. The biochemistry of ketogenesis and its role in weight management, neurological disease and oxidative stress. J Physiol Biochem 2012;68:141–51.
44. Haces ML, Hernandes-Fonseca K, Medina-Campos ON, Montiel T, Pedraza-Chaverri J, Massieu L. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol 2008;211:85–96.
45. Jain SK, Kannan K, Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic Biol Med 1998;25:1083–8.
46. Mohamed HE, El-Swefy SE, Rashed LA, Abd El-Latif SK. Biochemical effect of a ketogenic diet on the brains of obese adult rats. J Clin Neurosci 2010;17:899–904.
47. Nazarewicz RR, Ziolkowski W, Vaccaro PS, Ghafourifar P. Effect of short-term ketogenic diet on redox status of human blood. Rejuvenation Res 2007;10:435–40.
48. Beisswenger BGK, Delucia EM, Lapoint N, Sanford RJ, Beisswenger PJ. Ketosis leads to increased methylglyoxal production on the Atkins diet. Ann N YAcad Sci 2005;1043:201–10.
49. Tsai WC, Li YH, Lin CC, Chao TH, Chen JH. Effects of oxidative stress on endothelial function after a high-fat meal. Clin Sci (Lond) 2004;106:315–9.
50. Kotani K, Tsuzaki K, Taniguchi N, Sakane N. LDL Particle size and reactive oxygen metabolites in dyslipidemic patients. Int J Prev Med 2012;3:160.
51. Stan S, Levy E, Delvin EE, Hanley JA, Lamarche B, O’Loughlin, Paradis G, Lambert M. Distribution of LDL particle size in a population-based sample of children and adolescents and relationship with other cardiovascular risk factors. Clin Chem 2005;51:1192–200.
52. Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006;17:412–7.
53. Rizzo M, Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM 2006;99:1–14.
54. Sharman MJ, Kraemer WJ, Love DM, Avery NG, Gómez AL, Scheett TP, et al. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr 2002;132:1879–85.
55. Westman EC, Yancy W, Olsen MK, Dudley T, Guyton JR. Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int J Cardiol 2006;110:212.